Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NQ: BTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Brooklyn ImmunoTherapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
Brooklyn ImmunoTherapeutics Stock Rises After Novellus Therapeutics Buyout Deal
Brooklyn ImmunoTherapeutics LLC (NYSE: BTX) has executed a non-binding letter of intent to acquire Novellus Therapeutics, a company developing engineered... 
Via Benzinga
Brooklyn Immunotherapeutics Stock Is a Worthy Bet on Genetics Research
BTX stock holders will certainly want to brace for volatility. Still, the outlook's bullish as the company pursues its game-changing research. 
Via InvestorPlace
64 Biggest Movers From Friday
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... 
Via Benzinga
Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company’s Future During May 25, 2021 Shareholder Update Call
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
68 Biggest Movers From Yesterday
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached... 
Via Benzinga
22 Stocks Moving in Wednesday's Pre-Market Session
Gainers Nabriva Therapeutics plc (NASDAQ: NBRV) rose 48.8% to $2.20 in pre-market trading. Sinovant Sciences and Nabriva Therapeutics disclosed topline results from Phase 3 trial... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended... 
Via Benzinga
Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
52 Biggest Movers From Yesterday
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,... 
Via Benzinga
Exposures Product Safety
Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
48 Biggest Movers From Friday
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug... 
Via Benzinga
New CEO and Exclusive License Will Bolster Brooklyn Immunotherapeutics
Is change at the C-suite level a good thing for a company? The facts seem to indicate that it's a positive development for BTX stock holders. 
Via InvestorPlace
Brooklyn ImmunoTherapeutics to Conduct Shareholder Update Conference Call Tuesday May 25, 2021 at 4:30 PM ET
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
58 Biggest Movers From Yesterday
Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on... 
Via Benzinga
Publication In Breast Cancer Research Indicate Brooklyn ImmunoTherapeutics' IRX-2 May Hold Promise In Early-Stage Breast Cancer
Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF)... 
Via Benzinga
74 Biggest Movers From Friday
Gainers MoSys, Inc. (NASDAQ: MOSY) shares climbed 50.5% to settle at $4.35 on Friday. MoSys, last week, reported a loss for its first quarter. HyreCar Inc. (NASDAQ: HYRE) shares... 
Via Benzinga
Brooklyn ImmunoTherapeutics Announces Publication of Results of IRX-2 Monotherapy in Early Stage Breast Cancer in Breast Cancer Research
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
Why Brooklyn ImmunoTherapeutics Stock Crushed It in April
This clinical-stage biotech was one of April's brightest stars. 
Via The Motley Fool
Erich Mohr, Ph.D., to Join the Board of Directors of Brooklyn ImmunoTherapeutics
From Brooklyn ImmunoTherapeutics, Inc.
Via Business Wire
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics. iBio, Inc. (NYSE: IBIO) rose 29.5... 
Via Benzinga
70 Biggest Movers From Yesterday
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters... 
Via Benzinga
Up 1,300% in the Past Month, Is This Mysterious Biotech a Buy?
An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum? 
Via The Motley Fool
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors. Chiasma, Inc. (NASDAQ: CHMA) gained 53... 
Via Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target... 
Via Benzinga
Exposures COVID-19
64 Biggest Movers From Yesterday
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
Exposures COVID-19
26 Stocks Moving in Tuesday's Pre-Market Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares rose 60.5% to $1.99 in pre-market trading. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
Exposures COVID-19
52 Biggest Movers From Yesterday
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)... 
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Rises 1.5%; AVROBIO Shares Plummet
Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Mid-Day Market Update: Nasdaq Drops 50 Points; Ocugen Shares Spike Higher
Midway through trading Monday, the Dow traded up 0.92% to 34,187.80 while the NASDAQ fell 0.37% to 13,910.67. The S&P also rose, gaining 0.36% to 4,196.13. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.